Victrex (VCT) investor relations material

Executive summary

• Revenue increased 1% year-over-year to £147.1m, driven by 6% volume growth, with a weak Q1 offset by a strong Q2.

• Underlying profit before tax (PBT) fell 18% to £19.0m, impacted by adverse mix, pricing pressure, and currency headwinds.

• Gross margin declined to 41.7%, down 240bps, due to price pressure, mix, and currency.

• A non-cash impairment of £60.6m was recorded for the China plant, reflecting operational challenges and lower-than-expected capacity.

• Profit Improvement Plan underway, including a 10% global headcount reduction and new decentralized structure, targeting £10m annualised cost savings by FY 2027.

Financial highlights

• Revenue: £147.1m (+1% year-over-year, +2% constant currency); group sales volume up 6% to 2,137 tonnes.

• Gross profit: £61.3m, down 5% year-over-year; gross margin: 41.7% (down from 44.1%).

• Underlying PBT: £19m (down 18% year-over-year); underlying EPS: 17.2p (down 24%).

• Free cash flow: £22m, stable year-over-year; operating cash conversion at 109%.

• Net debt: £45.4m (0.65x net debt/EBITDA), supported by new term loan and continued use of RCF.

Outlook and guidance

• FY 2026 underlying PBT expected between £42m–£44m.

• Full-year gross margin expected slightly below prior year (45.3%), with H2 improvement anticipated.

• Exceptional items for FY 2026 anticipated at £75m–£85m, mainly from China impairment.

• CapEx to remain below 8–10% of revenues; H2 2026 to benefit from early cost savings.

• Capital Markets Day scheduled for September to detail strategy and medium-term ambitions.